Together, these data suggest that the increased sensitivity of colon carcinoma cells to doxorubicin-induced apoptosis by TRIM25 silencing results from convergent activation of mitochondrial apoptosis (via silencing of TRIM25) and drug-mediated activation of receptor-triggered apoptosis. Here, TRIM25 is linked to colon carcinoma.